Yun-Peng Yang

机构：Shenyang Aerospace University, Sun Yat-sen University, Jinan University, Chinese Academy of Sciences, Center for Excellence in Brain Science and Intelligence Technology, Hansoh Pharma (China), Sun Yat-sen University Cancer Center, Shanghai Center for Brain Science and Brain-Inspired Technology, Yangzhou University

发表论文 16 篇 · 总被引 304 次 · h-index 10

代表论文

• Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 61)
• Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo (2014 · Drug Design Development and Therapy · 被引 48)
• Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs (2016 · PLoS ONE · 被引 39)
• Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies (2016 · The Oncologist · 被引 28)
• The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer (2018 · Journal of Cancer · 被引 24)
• A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma (2016 · OncoTargets and Therapy · 被引 24)